BOS 0.00% 1.5¢ biosignal limited

quarterly cash burn

  1. 3,548 Posts.
    lightbulb Created with Sketch. 12
    Only $17k spent in last quarter because of collaborations and grants...amazing really.

    With ~$4.9m in the bank, BOS will surely be focused on finalising trials and development of the contact lenses. Looking good for 07 product release IMO.

    Looking forward to other product development updates, particularly medical devices and oil & gas industry piping.

    Surely its only a matter of time before this one flies...
 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.